S
Scilex Holding Company D
D
SCLX
1.12000
USD
0.06
(5.66%)
مفتوح الان
حجم التداول
24,281
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
147,528,567
العنوان: Scilex Holding Company
القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.